Do Outcomes between Women and Men Differ after Endovascular Thrombectomy? A Meta-analysis

References

1. 1.↵
   2. Potts J,
   3. Sirker A,
   4. Martinez SC, et al

   . Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: insights from 6.6 million PCI procedures in the United States. PLoS One 2018;13:e0203325 doi:10.1371/journal.pone.0203325 pmid:30180201

   CrossRefPubMed
2. 2.↵
   2. Appelros P,
   3. Stegmayr B,
   4. Terént A

   . Sex differences in stroke epidemiology: a systematic review. Stroke 2009;40:1082–90 doi:10.1161/STROKEAHA.108.540781 pmid:19211488

   Abstract/FREE Full Text
3. 3.↵
   2. Reid JM,
   3. Dai D,
   4. Gubitz GJ, et al

   . Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke 2008;39:1090–95 doi:10.1161/STROKEAHA.107.495143 pmid:18292386

   Abstract/FREE Full Text
4. 4.↵
   2. Bushnell C,
   3. Howard VJ,
   4. Lisabeth L, et al

   . Sex differences in the evaluation and treatment of acute ischaemic stroke. Lancet Neurol 2018;17:641–60 doi:10.1016/S1474-4422(18)30201-1 pmid:29914709

   CrossRefPubMed
5. 5.↵
   2. de Ridder IR,
   3. Fransen PS,
   4. Beumer D, et al

   . Is intra-arterial treatment for acute ischemic stroke less effective in women than in men. Interv Neurol 2016;5:174–78 doi:10.1159/000447331 pmid:27781046

   CrossRefPubMed
6. 6.↵
   2. Chalos V,
   3. de Ridder IR,
   4. Lingsma HF, et al

   . HERMES Collaborators. Does sex modify the effect of endovascular treatment for ischemic stroke? Stroke 2019;50:2413–19 doi:10.1161/STROKEAHA.118.023743 pmid:31412753

   CrossRefPubMed
7. 7.↵
   2. Uchida K,
   3. Yoshimura S,
   4. Sakai N, et al

   . RESCUE-Japan Registry 2 Investigators. Sex differences in management and outcomes of acute ischemic stroke with large vessel occlusion. Stroke 2019;50:1915–18 doi:10.1161/STROKEAHA.119.025344 pmid:31167622

   CrossRefPubMed
8. 8.↵
   2. Moher D,
   3. Liberati A,
   4. Tetzlaff J, et al

   . PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med 2009;6:e1000097 doi:10.1371/journal.pmed.1000097 pmid:19621072

   CrossRefPubMed
9. 9.↵
   2. Wells GA,
   3. Shea B,
   4. Connell D, et al

   . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Scale Vol 2000. http://www.evidencebasedpublichealth.de/download/Newcastle_Ottowa_Scale_Pope_Bruce.pdf. Accessed October 1, 2020
10. 10.↵
    2. Higgins JP,
    3. Altman DG,
    4. Gotzsche PC, et al

    . Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928 doi:10.1136/bmj.d5928 pmid:22008217

    FREE Full Text
11. 11.↵
    2. Briggs DE,
    3. Felberg RA,
    4. Malkoff MD, et al

    . Should mild or moderate stroke patients be admitted to an intensive care unit? Stroke 2001;32:871–76 doi:10.1161/01.STR.32.4.871 pmid:11283385

    Abstract/FREE Full Text
12. 12.↵
    2. Higgins JP,
    3. Thompson SG

    . Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58 doi:10.1002/sim.1186 pmid:12111919

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Liu F,
    3. McCullough LD

    . Interactions between age, sex, and hormones in experimental ischemic stroke. Neurochem Int 2012;61:1255–65 doi:10.1016/j.neuint.2012.10.003 pmid:23068990

    CrossRefPubMed
14. 14.↵
    2. Towfighi A,
    3. Saver JL,
    4. Engelhardt R, et al

    . A midlife stroke surge among women in the United States. Neurology 2007;69:1898–1904 doi:10.1212/01.wnl.0000268491.89956.c2 pmid:17581944

    Abstract/FREE Full Text
15. 15.↵
    2. Liu F,
    3. Yuan R,
    4. Benashski SE, et al

    . Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009;29:792–802 doi:10.1038/jcbfm.2009.5 pmid:19223913

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Hametner C,
    3. MacIsaac RL,
    4. Kellert L, et al

    . VISTA Collaborators. Sex and stroke in thrombolyzed patients and controls. Stroke 2017;48:367–74 doi:10.1161/STROKEAHA.116.014323 pmid:28028149

    Abstract/FREE Full Text
17. 17.↵
    2. Liu M,
    3. Li G,
    4. Tang J, et al

    . The influence of sex in stroke thrombolysis: a systematic review and meta-analysis. J Clin Neurol 2018;14:141–52 doi:10.3988/jcn.2018.14.2.141 pmid:29629522

    CrossRefPubMed
18. 18.↵
    2. Ribo M,
    3. Montaner J,
    4. Molina C, et al

    . Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. Thromb Haemost 2004;91:1146–51 doi:10.1160/TH04-02-0097 pmid:15175801

    CrossRefPubMed
19. 19.↵
    2. Shahar E,
    3. Folsom AR,
    4. Salomaa VV, et al

    . Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Circulation 1996;93:1970–75 doi:10.1161/01.cir.93.11.1970 pmid:8640970

    Abstract/FREE Full Text
20. 20.↵
    2. Viscoli CM,
    3. Brass LM,
    4. Kernan WN, et al

    . A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001;345:1243–49 doi:10.1056/NEJMoa010534 pmid:11680444

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Anderson G,
    3. Limacher M,
    4. Annlouise A, et al

    . Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12 doi:10.1001/jama.291.14.1701 pmid:15082697

    CrossRefPubMedWeb of Science